EMCDDA news
Using open-source information to improve the European drug monitoring system
Drug precursor developments in the European Union
Highlights from the EU Drug Markets Report for policy and practice
Methamphetamine in Europe: EMCDDA-Europol threat assessment
EMCDDA pilot study of drug-related homicide in Finland, the Netherlands and Sweden
New report highlights wide-ranging impacts of EU drug markets on health and security
2019 EU Drug Markets Report from The EMCDDA and Europol 21.11.2019
Europeans are spending at least EUR 30 billion on drugs each year at retail level, making the drug market a major source of income for organised crime groups in the European Union. This figure is announced today in the 2019 EU Drug Markets Report, released by the EU drugs agency (EMCDDA) and Europol (1).
Čtěte více
EU Drug Markets Report 2019
Coming soon: 2019 EU Drug Markets Report from the EMCDDA and Europol
Latest strategic analysis of the European Drug Market 18.11.2019
Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today. Understanding the reality of the European drug market requires a holistic approach, following the supply chain from production and trafficking to distribution and sales.
Čtěte více
EU Agencies join 10-year anniversary of EU’s Fundamental Rights Charter
The nine EU Justice and Home Affairs Agencies are marking the 10-year anniversary of the EU’s Charter of Fundamental Rights by pledging to continue to respect and promote fundamental rights throughout the work.
'The European Monitoring Centre for Drugs and Drug Addiction contributes to a healthier and more secure Europe by enabling better informed decisions and actions on drugs. Protecting fundamental rights is a priority for our work and all our activities are underpinned by the principles embodied in the Charter.' 12.11.2019
Čtěte více
EMCDDA Best practice portal update
Neurostimulation techniques for the treatment of substance use 08.11.2019
Čtěte více
